Burden of Illness Associated with Peripheral and Central Neuropathic Pain among Adults Seeking Treatment in the United States: A Patient‐Centered Evaluation

By  

PAIN MEDICINE, Vol. 15, Iss. 12, 2014-12 ,pp. : 2105-2119

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK

By Beard S. M.   McCrink L.   Le T. K.   Garcia-Cebrian A.   Monz B.   Malik R. A.  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 385-399

Informa Healthcare

Access to resources Recommend Favorite

Safety and Efficacy of Duloxetine in the Treatment of Diabetic Peripheral Neuropathic Pain in Older Patients

By  

Current Drug Safety, Vol. 4, Iss. 1, 2009-01 ,pp. : 22-29

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain*

By Boulanger Luke   Zhao Yang   Foster Talia S.   Fraser Kimberly   Bledsoe Stacey L.   Russell Mason W.  

Current Medical Research and Opinion, Vol. 25, Iss. 7, 2009-07 ,pp. : 1763-1773

Informa Healthcare

Access to resources Recommend Favorite

Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis

By Crucitti Antonio   Zhang Qi   Nilsson Mary   Brecht Stephan   Yang Charles R.   Wernicke Joachim  

Current Medical Research and Opinion, Vol. 26, Iss. 11, 2010-11 ,pp. : 2579-2588

Informa Healthcare

Access to resources Recommend Favorite